Table 1 Comparison of general information of patients

Age

43.52 ± 15.63

46.12 ± 14.58

0.323

Sex (male)

31 (54.39%)

49 (62.82%)

0.325

BMI^a

26.73 ± 4.75

25.52 ± 4.63

0.140

Comorbidities

    Diabetes mellitus

7

6

0.372

    Hypertension

4

5

0.834

    Others

2

4

0.978

Etiology

    Biliary

26 (45.61%)

34 (43.59%)

0.815

    Hypertriglyceridemia

12 (21.05%)

15 (19.23%)

0.794

    Alcoholic

8 (14.04%)

15 (19.23%)

0.575

    Idiopathic

6 (10.53%)

8 (10.26%)

0.814

    Others

5 (8.77%)

6 (7.69%)

0.927

APACHE II

13.47 ± 3.16

12.81 ± 3.40

0.253

Ranson score

5.01 ± 1.28

4.77 ± 1.23

0.273

MCTSI^a

6.05 ± 1.72

5.91 ± 1.56

0.623

    Necrotic score

3.27 ± 1.41

3.32 ± 1.38

0.837

No. of regional fluid collection

4.63 ± 1.12

4.57 ± 1.18

0.805

IAP^a (mmHg)

18.61 ± 3.47

18.09 ± 2.95

0.350

Early organ failure^b

26 (45.61%)

38 (48.72%)

0.721

    Respiratory failure

23 (40.35%)

31 (39.74%)

0.943

    Circulatory failure

12 (21.05%)

23 (29.49%)

0.269

    AKI^a

17(29.82%)

15 (19.23%)

0.153

Biochemical test

    Amylase (IU/L)

601.60 ± 447.82

586.89 ± 406.32

0.843

    Hematocrit (%)

42.37 ± 3.79

41.44 ± 4.00

0.175

    WBC^a count (×10⁹/L)

14.75 ± 3.18

15.41 ± 3.62

0.273

    CRP (mg/L)

67.97 ± 35.76

64.38 ± 33.20

0.549

    Ca²⁺ (mmol/L)

2.02 ± 0.20

2.01 ± 0.20

0.775

    Creatinine (µmol/L)

77 (39–542)

75 (35–437)

0.345